Epidemiology and Burden of Illness

Scott Smilen, MD
NYU Lagone Medical Center
New York, NY

Didactic Lecture

Viewing Options

Webcast

Topic Information

Target Audience

This enduring activity has been designed to meet the educational needs of gastroenterologists, colorectal surgeons, urogynecologists, physician assistants, nurse practitioners and nurses involved in the care of patients with fecal incontinence.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe the epidemiology and burden of illness, pathophysiology, and diagnostic evaluation of fecal incontinence latest evidence regarding the pathophysiology of fecal incontinence

Discuss the relative benefits and risks of medical and surgical approaches for the management of patients with fecal incontinence

Formulate an appropriate treatment plan for patients with fecal incontinence based on clinical presentation and patient preference

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Gi Health Foundation.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s) . Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Release Date: March 25, 2015Expiration Date: March 25, 2016   
*This program has expired. CME credit is no longer available.

Disclosure of Conflicts of Interest:

All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education (ACHS), consults for Pfizer, Inc.; John Bayliss, VP, Business Development, partner is an employee of Amgen, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and GiHealth Foundation have no relationships to disclose.

Dr. Scott Smilen has no relationships to disclose

Learner Assurance Statement:

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

This program is supported by an Educational grant from Salix Pharmaceuticals, Inc.

© Copyright 2013-2017 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.